trending Market Intelligence /marketintelligence/en/news-insights/trending/cpmcll6795hqhmrvznszyw2 content esgSubNav
In This List

Convatec CEO retires; interim named

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Convatec CEO retires; interim named

Convatec Group PLC said Paul Moraviec will retire as CEO and will no longer be a board member, effective immediately.

The U.K.-based company appointed its nonexecutive director Rick Anderson, former group chairman of Johnson & Johnson, as interim CEO with immediate effect. Anderson will cease to be a member of the audit and risk committee, effective immediately.

The company said Moraviec will be available to ensure an orderly transition.

Convatec develops and markets medical products and technologies and is focused on therapies for managing chronic conditions, including wound care and ostomy care.